eFFECTOR Therapeutics, Inc. (EFTR) Financials

EFTR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 27.1 million 26.3 million
Dec. 31, 2023 20.5 million 26.3 million
Sept. 30, 2023 20.2 million 24.1 million
June 30, 2023 26.9 million 24.3 million

EFTR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -7.3 million 1.0 million
Dec. 31, 2023 -5.6 million 1.1 million
Sept. 30, 2023 -7.8 million 1.1 million
June 30, 2023 -8.6 million 1.2 million

EFTR Net Income

No data available :(

EFTR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 25.4 million - 232000
Dec. 31, 2023 18.4 million - 60000
Sept. 30, 2023 17.8 million 6000 77000
June 30, 2023 25.0 million 25000 94000

EFTR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 ?
Dec. 31, 2023 ?
Sept. 30, 2023 2.5 million
June 30, 2023 1.9 million

EFTR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 - 5.3 million 3.1 million -
Dec. 31, 2023 54000 6.0 million 2.5 million -
Sept. 30, 2023 2000 5.4 million 2.5 million -
June 30, 2023 28000 4.9 million 3.0 million -

EFTR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 - 28000
Dec. 31, 2023 162000 30000
Sept. 30, 2023 - 26000
June 30, 2023 - 27000

EFTR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EFTR

Price: $0

52 week price:
0.00
0.01

Earnings Per Share: -12.57 USD

P/E Ratio: -0.65

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 547000

Market Capitalization: 941

Links: